The bottom line is that
all three patients saw symptoms disappear and major health restoration on an
ongoing basis. So why would you do
anything else first? Yes, it is early
days, but the protocol is clearly safe.
Let me spell this out a
little clearer. Any doctor not applying
this protocol immediately to all diagnosed with hepatitis C is now guilty of
outright malpractice. If you wish to
argue otherwise, I suggest you save it up for the jury. This happens to be huge breakthrough for this
disease.
My point is that three
human beings, not mice walked away from major surgery once and likely for all
time. It does not get any better. Yes I would like to do a couple hundred
additional patients, but that can be in course of treatment any way. There may even be a low probability anomaly
after all.
The hepatitis C study
America never heard about - The Berkson Clinical Study
Thursday,
July 25, 2013 by: Tony Isaacs
http://www.naturalnews.com/041341_Berkson_Clinical_Study_hepatitis_C_liver_health.html#ixzz2aApwKF7u
(NaturalNews)
If someone were to take a look at the impressive credentials of Dr. Burton
Berkson they would likely think that any study he conducted would easily find
its way to publication - especially one which demonstrated remarkable success
against chronic hepatitis C.
Such was not the case with the Berkson Clinical Study in the U.S., despite Dr. Berkson's credentials. Instead, the U.S. study ended up being published in the German medical journal Medizinishche Klinik.
A
sample of Dr. Berkson's credentials:
Assist.
Professor, Rutgers University
Assoc.
Professor, Chicago State University
Visiting
Professor, Max Planck Institute
Consultant
Mushroom Poisoning, Centers for Disease Control and Prevention
Toxicology
Consultant, New Mexico Poison Control Center
Principal
Investigator, FDA, IV Thiocatic Acid (Alpha-Lipoic Acid)
Member,
New Mexico Medical/Legal Panel
Attending
Physician, White Sands Missile Range
Member,
El Paso Fund Alternative Medicine Committee
President
of the Integrative Medical Center of New Mexico
Why
the study wasn't published in the U.S.
The
last two items in the credentials may give a hint of why Berkson's study was
never published in America. The real publication killer; however, was likely
the fact that the study used a non-patentable, inexpensive therapy of common
dietary supplements and healthy dietary and lifestyle changes which had an
estimated cost of less than $2,000 per year. Such a low cost would be quite a
threat to the profits mainstream medicine rakes in on hepatitis
C.
An estimated 3.2 million people in the U.S. have chronic hepatitis C, a contagious liver disease that results from infection with the hepatitis C virus. 17,000 people are newly infected with the hepatitis C virus each year and 85 percent go on to develop chronic hepatitis. Mainstream medicine essentially offers two treatment options: antiviral treatments (such as interferon) or liver transplants.
Antiviral treatment costs range well upwards of tens of thousands of dollars annually. The treatments are successful no more than 30 percent of the time and side effects can be horrific, especially so with interferon.
Liver transplant surgery costs $300,000 or more during the first three months alone - plus the continued costs of thousands of dollars for anti-rejection drugs and healthcare facility visits. It too can be painful and debilitating. The 15 year survival rate is about 58 percent.
The
Berkson Clinical Study
In
the Berkson Clinical Study, three patients were selected at random from a
group of about 50 chronic hepatitis C charts at the Integrative Medical
Center of New Mexico in Las Cruces. Each patient was given daily doses of
the antioxidants alpha lipoic acid, milk thistle (silymarin) and selenium
(selenomethiomine).
The patients also took vitamins B, C, and E and a mineral supplement each day. They were requested to eat a diet that included at least six servings of fresh vegetables and fruits, four ounces or fewer of meat per meal, and eight glasses of water. It was also suggested that they reduce stress and exercise, including at least a one-mile walk three times a week.
The
patients
One
of the patients had been treated with steroids and interferon without success.
A mass in her liver was diagnosed as probable cancer and she was told there was
no hope. Another patient had similarly been treated with interferon without
success. She had been told a liver transplant was her only option. The third
patient was on the verge of transplant surgery when she decided to investigate
a more conservative approach.
[ all three were
immediate liver transplant candidates ]
The
results
From
the study's conclusion:
"All three women recovered quickly and their laboratory values remarkably improved. Furthermore, liver transplantation was avoided and the patients are back at work, carrying out their normal activities, and feeling healthy."
Sources:
http://www.ncbi.nlm.nih.gov/pubmed/10554539
http://www.tbyil.com/berkson.htm
http://hepatitis.about.com/od/overview/a/numbers.htm
http://www.viralhepatitisaction.org/hepatitis-c
About the author:
Tony Isaacs, is a natural health author, advocate and researcher who hosts The Best Years in Life website for those who wish to avoid prescription drugs and mainstream managed illness and live longer, healthier and happier lives naturally. Mr. Isaacs is the author of books and articles about natural health, longevity and beating cancer including "Cancer's Natural Enemy" and is working on a major book project due to be published later this year.
Mr. Isaacs also hosts the Yahoo Oleandersoup group of over 2600 members and the The Best Years in Life Radio Show" on Wolf Spirit Radio.
No comments:
Post a Comment